OrbiMed Capital GP VIII LLC's Net Worth

$0

Estimate Recalculated Jan 4, 2025 01:02AM EST

Who is OrbiMed Capital GP VIII LLC

OrbiMed Capital GP VIII LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Janux Therapeutics, Inc., Decibel Therapeutics, Inc., Kinnate Biopharma Inc., Disc Medicine, Inc., and Traws Pharma, Inc..

SEC CIK

OrbiMed Capital GP VIII LLC's CIK is 0001845804

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ArriVent Biopharma, Inc.

Investor
Updated Jan 31, 2024
Form 4
9.46%
444.44K
$18.00
$4.00M
Jan 31, 2024
5.14M
Purchase
Jan 30
Form 3
Jan 25, 2024
Showing 2 results

Janux Therapeutics, Inc.

Investor
Updated Dec 30, 2021
Form 4
-1.60%
-40.40K
$20.30
-$820.12K
Dec 30, 2021
2.49M
Sale
Dec 29
Form 4
-4.51%
-119.40K
$19.00
-$2.27M
Dec 23, 2021
2.53M
Sale
Dec 21
Form 4
66.79%
1.22M
$17.00
Jun 16, 2021
3.04M
Purchase
Jun 15
Form 3
Jun 10, 2021
Showing 4 results

Decibel Therapeutics, Inc.

Investor
Updated Feb 19, 2021
Form 4
-60.83%
-12.43M
$18.00
$30.00M
Feb 19, 2021
8.01M
Buy-Options
Feb 17
Form 3
Feb 11, 2021
Showing 2 results

Kinnate Biopharma Inc.

Investor
Updated Apr 05, 2024
Form 4
-100.00%
-8.01M
Apr 05, 2024
Disposition
Apr 03
Form 4
21.20%
1.46M
$2.78
$4.09M
May 08, 2023
8.89M
Purchase
May 04 - May 05
Form 4
10.11%
1.41M
$2.61
$3.67M
May 02, 2023
15.84M
Purchase
Apr 28 - May 02
Form 4
1.10M
Feb 23, 2023
5.14M
Grant
Feb 17
Form 3
Feb 23, 2023
1.10M
Showing 5 results

Disc Medicine, Inc.

Investor
Updated Jun 20, 2024
Form 4
4.90%
83.33K
$36.00
$3.00M
Jun 20, 2024
1.79M
Purchase
Jun 17
Form 4
-100.00%
-1.72K
$48.62
-$36.62K
Dec 20, 2023
1.70M
Sale
Dec 18
Form 4
-20.29%
-433.20K
$56.75
-$24.58M
Dec 15, 2023
1.70M
Sale
Dec 14
Form 4
-2.11%
-134.20K
$58.95
-$7.90M
Dec 14, 2023
6.23M
Sale
Dec 12 - Dec 14
Form 4
5.03%
108.70K
$23.00
$2.50M
Feb 17, 2023
2.27M
Purchase
Feb 15
Form 4
2.16M
Jan 03, 2023
2.16M
Acq/Dis
Dec 29
Form 3
Jan 03, 2023
1.58M
Showing 7 results

Traws Pharma, Inc.

Investor
Updated Apr 12, 2024
Form 3/A
Apr 12, 2024
1.05M
Form 3
Apr 03, 2024
885.53K
Showing 2 results

Upstream Bio, Inc.

Investor
Updated Oct 17, 2024
Form 4
16.95%
825.00K
$17.00
Oct 17, 2024
5.69M
Purchase
Oct 15
Form 3
Oct 10, 2024
1.26M
Showing 2 results

Lomond Therapeutics Holdings, Inc.

Investor
Updated Nov 05, 2024
Form 4
117.04%
1.44M
$3.74
$10.00M
Nov 05, 2024
2.68M
Options
Nov 01
Form 3
Nov 05, 2024
Showing 2 results